Edition:
India

Evoke Pharma Submits Response To FDA Review Letter For Gimoti NDA


Thursday, 14 Mar 2019 

March 14 (Reuters) - Evoke Pharma Inc ::EVOKE PHARMA SUBMITS RESPONSE TO FDA REVIEW LETTER FOR GIMOTI™ NDA.EVOKE PHARMA INC - REQUESTED A MEETING WITH FDA PRIOR TO PRESCRIPTION DRUG USER FEE ACT (PDUFA) ACTION DATE OF APRIL 1, 2019..EVOKE PHARMA INC - FDA MEETING WAS GRANTED AND WILL BE HELD ON MARCH 21, 2019.. 

Company Quote

0.951
0.001 +0.11%
20 Sep 2019